1035 related articles for article (PubMed ID: 17977701)
21. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
22. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
[TBL] [Abstract][Full Text] [Related]
23. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
Sawicki W; Lunio R
Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
[TBL] [Abstract][Full Text] [Related]
24. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
Maejima T; McGinity JW
Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
[TBL] [Abstract][Full Text] [Related]
25. Compression of pellets coated with various aqueous polymer dispersions.
Dashevsky A; Kolter K; Bodmeier R
Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
[TBL] [Abstract][Full Text] [Related]
26. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
27. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
Hosseini A; Körber M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
[TBL] [Abstract][Full Text] [Related]
28. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
29. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
Devrim B; Canefe K
Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
[TBL] [Abstract][Full Text] [Related]
31. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
32. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
Sungthongjeen S; Paeratakul O; Limmatvapirat S; Puttipipatkhachorn S
Int J Pharm; 2006 Nov; 324(2):136-43. PubMed ID: 16828997
[TBL] [Abstract][Full Text] [Related]
33. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
[TBL] [Abstract][Full Text] [Related]
34. Mechanical properties of excipients do not affect polymer matrix formation.
Chatterjee L; Rades T; Tucker IG
Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
[TBL] [Abstract][Full Text] [Related]
35. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
36. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
Nerurkar J; Jun HW; Price JC; Park MO
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
[TBL] [Abstract][Full Text] [Related]
37. A novel compression-coated doughnut-shaped tablet design for zero-order sustained release.
Sundy E; Danckwerts MP
Eur J Pharm Sci; 2004 Aug; 22(5):477-85. PubMed ID: 15265518
[TBL] [Abstract][Full Text] [Related]
38. Effects of film coating thickness and drug layer uniformity on in vitro drug release from sustained-release coated pellets: a case study using terahertz pulsed imaging.
Ho L; Cuppok Y; Muschert S; Gordon KC; Pepper M; Shen Y; Siepmann F; Siepmann J; Taday PF; Rades T
Int J Pharm; 2009 Dec; 382(1-2):151-9. PubMed ID: 19716407
[TBL] [Abstract][Full Text] [Related]
39. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
[TBL] [Abstract][Full Text] [Related]
40. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
Dave VS; Fahmy RM; Hoag SW
Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]